7+3 regimen

WikiDoc Resources for 7+3 regimen
Articles
Most recent articles on 7+3 regimen Most cited articles on 7+3 regimen Review articles on 7+3 regimen Articles on 7+3 regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on 7+3 regimen Images of 7+3 regimen Photos of 7+3 regimen Podcasts & MP3s on 7+3 regimen Videos on 7+3 regimen
Evidence Based Medicine
Cochrane Collaboration on 7+3 regimen Bandolier on 7+3 regimen TRIP on 7+3 regimen
Clinical Trials
Ongoing Trials on 7+3 regimen at Clinical Trials.gov Trial results on 7+3 regimen Clinical Trials on 7+3 regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on 7+3 regimen NICE Guidance on 7+3 regimen NHS PRODIGY Guidance FDA on 7+3 regimen CDC on 7+3 regimen
Books
Books on 7+3 regimen
News
7+3 regimen in the news Be alerted to news on 7+3 regimen News trends on 7+3 regimen
Commentary
Blogs on 7+3 regimen
Definitions
Definitions of 7+3 regimen
Patient Resources / Community
Patient resources on 7+3 regimen Discussion groups on 7+3 regimen Patient Handouts on 7+3 regimen Directions to Hospitals Treating 7+3 regimen Risk calculators and risk factors for 7+3 regimen
Healthcare Provider Resources
Symptoms of 7+3 regimen Causes & Risk Factors for 7+3 regimen Diagnostic studies for 7+3 regimen Treatment of 7+3 regimen
Continuing Medical Education (CME)
CME Programs on 7+3 regimen
International
7+3 regimen en Espanol 7+3 regimen en Francais
Business
7+3 regimen in the Marketplace Patents on 7+3 regimen
Experimental / Informatics
List of terms related to 7+3 regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen

Overview

7+3 regimen refers to an immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.

Regimen

R – Rituximab

C – Cyclophosphamide

H – Doxorubicin (Hydroxydaunomycin)

O – Vincristine (Oncovin)

P – Prednisone

Indications

• Diffuse large B-cell lymphoma, untreated
• Mantle cell lymphoma

See also

• ACVBP-R regimen
• CDOP regimen
• CHOEP regimen
• CHOP regimen
• CHOP Intensified regimen
• CHOP Modified regimen
• CNOP regimen
• DA-EPOCH regimen
• DA-R-EPOCH regimen
• LR-CHOP-21 regimen
• m-BACOD regimen
• MACOP-B regimen
• MCOP regimen
• ProMACE-CytaBOM regimen
• ProMACE-MOPP regimen
• R-CDOP regimen
• R-CEOP regimen
• R-CHMP regimen
• R-CHOEP-14 regimen
• R-CHOP Intensified regimen
• R-CVP regimen
• R-GCVP regimen
• R-HCVAD/R-MA regimen
• R-miniCEOP regimen
• R-miniCHOP regimen
• R2CHOP regimen
• VR-CHOP regimen